Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Feb;71(2):1370–1374. doi: 10.1128/jvi.71.2.1370-1374.1997

Hyper-antigenic variation occurs with human rhinovirus type 17.

L J Patterson 1, V V Hamparian 1
PMCID: PMC191192  PMID: 8995661

Abstract

Of 90 human rhinovirus (RV) serotypes tested, 50 can be placed into 16 groups according to antigenic relationships. It has been suggested that antigenic variants might arise in nature by immunologic pressure. To investigate this possibility, attempts were made to select variants by cloning 16 different plaque-purified RV serotypes in the presence of homologous, polyclonal antisera. Isolates were examined for evidence of variation in serum cross-neutralization tests using parental antisera and, in some cases, antisera prepared for the isolates. Only RV type 17 (RV-17) yielded major antigenic variants after cloning. With some variants, as much as a 500-fold difference in neutralizing titer was obtained with the parental antiserum. By using antisera for two of the variants, it was determined that they are prime strains of the parental RV-17. Continuing attempts at immunoselection by using antisera for one of these prime strains yielded additional antigenic variants. By using antisera prepared for three of these new variants, it was determined that one of them is a prime strain of the virus from which it was derived. Cross-neutralization tests with the two remaining isolates indicate that, according to conventional practice, they no longer would be classified as RV-17.

Full Text

The Full Text of this article is available as a PDF (175.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boege U., Kobasa D., Onodera S., Parks G. D., Palmenberg A. C., Scraba D. G. Characterization of Mengo virus neutralization epitopes. Virology. 1991 Mar;181(1):1–13. doi: 10.1016/0042-6822(91)90464-m. [DOI] [PubMed] [Google Scholar]
  2. Borrego B., Novella I. S., Giralt E., Andreu D., Domingo E. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol. 1993 Oct;67(10):6071–6079. doi: 10.1128/jvi.67.10.6071-6079.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carrillo C., Plana J., Mascarella R., Bergadá J., Sobrino F. Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology. 1990 Dec;179(2):890–892. doi: 10.1016/0042-6822(90)90162-k. [DOI] [PubMed] [Google Scholar]
  4. Conant R. M., Hamparian V. V. Rhinoviruses: basis for a numbering system. 1. HeLa cells for propagationand serologic procedures. J Immunol. 1968 Jan;100(1):107–113. [PubMed] [Google Scholar]
  5. Cooney M. K., Fox J. P., Kenny G. E. Antigenic groupings of 90 rhinovirus serotypes. Infect Immun. 1982 Aug;37(2):642–647. doi: 10.1128/iai.37.2.642-647.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooney M. K., Kenny G. E. Reciprocal neutralizing cross-reaction between rhinovirus types 9 and 32. J Immunol. 1970 Aug;105(2):531–533. [PubMed] [Google Scholar]
  7. Cooney M. K., Kenny G. E., Tam R., Fox J. P. Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera. Infect Immun. 1973 Mar;7(3):335–340. doi: 10.1128/iai.7.3.335-340.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Domingo E., Dávila M., Ortín J. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene. 1980 Nov;11(3-4):333–346. doi: 10.1016/0378-1119(80)90073-6. [DOI] [PubMed] [Google Scholar]
  9. Gercel C., Mahan K. B., Hamparian V. V. Preliminary characterization of a persistent infection of HeLa cells with human rhinovirus type 2. J Gen Virol. 1985 Jan;66(Pt 1):131–139. doi: 10.1099/0022-1317-66-1-131. [DOI] [PubMed] [Google Scholar]
  10. Gerhard W., Webster R. G. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med. 1978 Aug 1;148(2):383–392. doi: 10.1084/jem.148.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HAMRE D., LOOSLI C. G., GERBER P. Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. J Exp Med. 1958 Jun 1;107(6):829–844. doi: 10.1084/jem.107.6.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HAMRE D., LOOSLI C. G., GERBER P. Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine. J Exp Med. 1958 Jun 1;107(6):845–855. doi: 10.1084/jem.107.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamparian V. V., Colonno R. J., Cooney M. K., Dick E. C., Gwaltney J. M., Jr, Hughes J. H., Jordan W. S., Jr, Kapikian A. Z., Mogabgab W. J., Monto A. A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology. 1987 Jul;159(1):191–192. doi: 10.1016/0042-6822(87)90367-9. [DOI] [PubMed] [Google Scholar]
  14. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science. 1982 Mar 26;215(4540):1577–1585. doi: 10.1126/science.7041255. [DOI] [PubMed] [Google Scholar]
  15. Howell R. M., Fitzgibbon J. E., Noe M., Ren Z. J., Gocke D. J., Schwartzer T. A., Dubin D. T. In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual. AIDS Res Hum Retroviruses. 1991 Nov;7(11):869–876. doi: 10.1089/aid.1991.7.869. [DOI] [PubMed] [Google Scholar]
  16. Hughes J. H., Thomas D. C., Hamparian V. V., Cramblett H. G. Acid liability of rhinovirus type 14: effect of pH, time, and temperature. Proc Soc Exp Biol Med. 1973 Nov;144(2):555–560. doi: 10.3181/00379727-144-37634. [DOI] [PubMed] [Google Scholar]
  17. Kinnunen L., Huovilainen A., Pöyry T., Hovi T. Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J Gen Virol. 1990 Feb;71(Pt 2):317–324. doi: 10.1099/0022-1317-71-2-317. [DOI] [PubMed] [Google Scholar]
  18. LOOSLI C. G., HAMRE D., GERBER P. Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series. J Exp Med. 1958 Jun 1;107(6):857–868. doi: 10.1084/jem.107.6.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Laver W. G., Webster R. G. Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutination proteins. Virology. 1968 Feb;34(2):193–202. doi: 10.1016/0042-6822(68)90230-4. [DOI] [PubMed] [Google Scholar]
  20. Minor P. D., Schild G. C., Ferguson M., Mackay A., Magrath D. I., John A., Yates J. P., Spitz M. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. J Gen Virol. 1982 Aug;61(Pt 2):167–176. doi: 10.1099/0022-1317-61-2-167. [DOI] [PubMed] [Google Scholar]
  21. Rocha E., Cox N. J., Black R. A., Harmon M. W., Harrison C. J., Kendal A. P. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol. 1991 May;65(5):2340–2350. doi: 10.1128/jvi.65.5.2340-2350.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rojas E. R., Carrillo E., Schiappacassi M., Campos R. Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera. J Virol. 1992 Jun;66(6):3368–3372. doi: 10.1128/jvi.66.6.3368-3372.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schieble J. H., Lennette E. H., Fox V. L. Antigenic variation of rhinovirus type 22. Proc Soc Exp Biol Med. 1970 Jan;133(1):329–333. doi: 10.3181/00379727-133-34468. [DOI] [PubMed] [Google Scholar]
  24. Sherry B., Mosser A. G., Colonno R. J., Rueckert R. R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol. 1986 Jan;57(1):246–257. doi: 10.1128/jvi.57.1.246-257.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stott E. J., Walker M. Antigenic variation among strains of rhinovirus type 51. Nature. 1969 Dec 27;224(5226):1311–1312. doi: 10.1038/2241311a0. [DOI] [PubMed] [Google Scholar]
  26. Thomas A. A., Woortmeijer R. J., Puijk W., Barteling S. J. Antigenic sites on foot-and-mouth disease virus type A10. J Virol. 1988 Aug;62(8):2782–2789. doi: 10.1128/jvi.62.8.2782-2789.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wain-Hobson S. The fastest genome evolution ever described: HIV variation in situ. Curr Opin Genet Dev. 1993 Dec;3(6):878–883. doi: 10.1016/0959-437x(93)90008-d. [DOI] [PubMed] [Google Scholar]
  28. Yurlova T. I., Sverkunova M. V., Furaeva V. A., Sukhinin V. P., Shitikova G. S., Fedová D., Kunzová L. Studies of natural population variability of parainfluenza viruses during their epidemic circulation. Acta Virol. 1991 Jan;35(1):64–70. [PubMed] [Google Scholar]
  29. Zwart G., Langedijk H., van der Hoek L., de Jong J. J., Wolfs T. F., Ramautarsing C., Bakker M., de Ronde A., Goudsmit J. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology. 1991 Apr;181(2):481–489. doi: 10.1016/0042-6822(91)90880-k. [DOI] [PubMed] [Google Scholar]
  30. de Jong J. C., de Ronde-Verloop F. M., Veenendaal-van Herk T. M., Weijers T. F., Bijlsma K., Osterhaus A. D. Antigenic heterogeneity within influenza A (H3N2) virus strains. Bull World Health Organ. 1988;66(1):47–55. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES